Corteva IncCTVA
▲ ポジティブ資本関連度
Corteva reported strong Q1 2026 results with 21% EBITDA growth and reaffirmed 2026 outlook, indicating solid financial performance.
銘柄への影響 2
Synthetic Biology (non-pharma)
Corteva IncClimate Adaptation & Water
FMC CorporationFMC
▼ ネガティブ競争関連度
Corteva's Crop Protection segment faced competitive pricing pressures in Latin America and Asia Pacific, which may affect FMC as a competitor in the same market.